Concepedia

The Effect of Subconjunctival Ranibizumab on Corneal and Anterior Segment Neovascularization: Study on an Animal Model

Vasilios S. Liarakos, Dimitrios Papaconstantinou, Ioannis Vergados, Maria Douvali, Panagiotis Theodossiadis

European Journal of Ophthalmology · 2013 · 31 citations · 44 references

DOI

Abstract

Early subconjunctival administration of ranibizumab may successfully inhibit alkali-induced corneal neovascularization in an animal model. Subconjunctival ranibizumab reduces VEGF levels significantly not only in the cornea and the bulbar conjunctiva but also in the aqueous humor and the iris.

References

44

Ranibizumab for Neovascular Age-Related Macular Degeneration

Philip J. Rosenfeld, David M. Brown, Jeffrey S. Heier et al. · New England Journal of Medicine · 2006 · 5.8K citations · Full text

Ranibizumab and Bevacizumab for Neovascular Age-Related Macular Degeneration

New England Journal of Medicine · 2011 · 2.6K citations · Full text

The RESTORE Study

Paul Mitchell, Francesco Bandello, Ursula Schmidt‐Erfurth et al. · Ophthalmology · 2011 · 1.3K citations · Full text

Sustained Benefits from Ranibizumab for Macular Edema following Central Retinal Vein Occlusion: Twelve-Month Outcomes of a Phase III Study

Peter A. Campochiaro, David M. Brown, Carl C. Awh et al. · Ophthalmology · 2011 · 698 citations

, , +6

Sustained Benefits from Ranibizumab for Macular Edema Following Branch Retinal Vein Occlusion: 12-Month Outcomes of a Phase III Study

David M. Brown, Peter A. Campochiaro, Robert B. Bhisitkul et al. · Ophthalmology · 2011 · 454 citations

, , +6